Novel treatments of fibrosis for hypertensive heart disease

Project: Research

Status	Finished
Effective start/end date	1/01/17 → 31/12/20

Preclinical rodent models of cardiac fibrosis
Wang, Y., Wang, M., Samuel, C. S. & Widdop, R. E., Mar 2022, In: British Journal of Pharmacology. 179, 5, p. 882-899 18 p.
Research output: Contribution to journal › Review Article › Research › peer-review

7 Citations (Scopus)
The Novel AT2 Receptor Agonist β-Pro7-AngIII Exerts Cardiac and Renal Anti-Fibrotic and Anti-Inflammatory Effects in High Salt-Fed Mice
Wang, Y., Yodgee, J., Del Borgo, M., Spizzo, I., Nguyen, L., Aguilar, M. I., Denton, K. M., Samuel, C. S. & Widdop, R. E., Nov 2022, In: International Journal of Molecular Sciences. 23, 22, 12 p., 14039.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

1 Citation (Scopus)
N-(Methyloxycarbonyl)thiophene sulfonamides as high affinity AT2 receptor ligands
Wannberg, J., Gising, J., Lindman, J., Salander, J., Gutiérrez-de-Terán, H., Ablahad, H., Hamid, S., Grönbladh, A., Spizzo, I., Gaspari, T. A., Widdop, R. E., Hallberg, A., Backlund, M., Leśniak, A., Hallberg, M. & Larhed, M., 1 Jan 2021, In: Bioorganic & Medicinal Chemistry. 29, 15 p., 115859.
Research output: Contribution to journal › Article › Research › peer-review

5 Citations (Scopus)

Project Details